Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C.
Borghi-Scoazec
Giovanna
G
Merle
Philippe
P
Scoazec
Jean-Yves
JY
Claudy
Alain
A
Trepo
Christian
C
D000998:Antiviral Agents / Q000009:adverse effects*; D003874:Dermatitis Herpetiformis / Q000209:etiology* / Q000276:immunology; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin